Citadel Advisors - CULLINAN ONCOLOGY INC ownership

CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 82 filers reported holding CULLINAN ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of CULLINAN ONCOLOGY INC
ValueSharesWeighting
Q3 2023$9,735,520
-14.8%
1,075,748
+1.3%
0.00%0.0%
Q2 2023$11,422,289
+78.0%
1,061,551
+69.2%
0.00%
+100.0%
Q1 2023$6,417,975
+146.7%
627,368
+154.4%
0.00%0.0%
Q4 2022$2,601,736
-22.5%
246,610
-5.9%
0.00%0.0%
Q3 2022$3,358,000
-34.0%
262,003
-34.0%
0.00%0.0%
Q2 2022$5,088,000
+80.7%
396,870
+47.5%
0.00%
Q1 2022$2,816,000
+292.7%
268,985
+478.7%
0.00%
Q4 2021$717,000
-70.1%
46,481
-56.2%
0.00%
Q3 2021$2,395,000
-9.8%
106,133
+2.9%
0.00%
-100.0%
Q2 2021$2,655,000
-42.8%
103,108
-7.4%
0.00%0.0%
Q1 2021$4,639,000111,3220.00%
Other shareholders
CULLINAN ONCOLOGY INC shareholders Q1 2022
NameSharesValueWeighting ↓
MPM BioImpact LLC 7,648,268$98,051,00027.24%
CHI Advisors LLC 3,047,609$39,070,00014.92%
Nextech Invest Ltd. 1,221,145$15,655,0005.28%
BVF INC/IL 7,509,059$96,266,0004.65%
TANG CAPITAL MANAGEMENT LLC 609,231$7,810,0001.18%
Boxer Capital, LLC 1,074,082$13,770,0000.87%
SILVERARC CAPITAL MANAGEMENT, LLC 213,090$2,732,0000.84%
Atom Investors LP 96,880$1,242,0000.54%
EcoR1 Capital, LLC 1,169,889$14,998,0000.52%
Birchview Capital, LP 45,114$578,0000.42%
View complete list of CULLINAN ONCOLOGY INC shareholders